Armed with a desire to utilize his skills and expertise for community service, Jorge Garcia-Zuazaga, MBA, MD, founder of Apex Dermatology and Skin Surgery Center in Ohio, created the Purple Heart Project. A nonprofit through which his practice offers free laser treatments to service members wounded in duty.
“Before I became a dermatologist, I was a flight surgeon for the Marines,” says Dr. Garcia...
Armed with a desire to utilize his skills and expertise for community service, Jorge...
The distinct dark color of excess pigmentation in the skin is the ideal target for...
There are dozens of industries that provide private label products to end users, from...
In his three-plus decades in private practice, Michael Niccole, MD, has seen his share...
Silagen Topical Recovery Gel from NewMedical Technology helps reduce...
The InMode AccuTite radiofrequency-assisted lipolysis (RFAL) device features...
Resurface Glycolic Renewal Serum from Neostrata features a 12 percent...
Cynosure TempSure Surgical radiofrequency (RF) technology—a new addition to...
 Endo International has received U.S. Food and Drug Administration (FDA) approval of QWO (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO is the first FDA-approved injectable treatment for cellulite. When injected...
|
 A recent survey from the American Society of Plastic Surgeons (ASPS) revealed the top surgical and nonsurgical cosmetic procedures of 2019 and offered predictions from 350 member surgeons on what aesthetic physicians can expect in the second half of 2020.
Sixty-eight percent of respondents...
|
Endo International has received U.S. Food and Drug Administration (FDA) approval of QWO (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO is the first FDA-approved injectable treatment for cellulite. When injected into the treatment area, QWO enzymatically releases the fibrous septae that tether to the skin causing the dimpling of cellulite by specifically targeting Types 1 and 3 collagen.
“Endo recognized a significant unmet need for an effective and noninvasive injectable treatment for cellulite, which led us to conduct the largest clinical trials in the history of cellulite investigation in the United States,” said Matthew Davis, MD, RPh, senior vice president and chief medical officer of Endo. “Supported by rigorous research, testing and development processes, we are proud to have received FDA approval of the first injectable treatment for cellulite in the buttocks, and we look forward to delivering QWO to the aesthetics community and their adult female patients.”
The company expects to have QWO available throughout the United States starting in Spring 2021. For more information and to sign up for updates on product availability,...
A recent survey from the American Society of Plastic Surgeons (ASPS) revealed the top surgical and nonsurgical cosmetic procedures of 2019 and offered predictions from 350 member surgeons on what aesthetic physicians can expect in the second half of 2020.
Sixty-eight percent of respondents started seeing patients virtually because of COVID-19, and member-surgeons felt that the continued interest in plastic surgery procedures during the COVID-19 pandemic suggests patient confidence in plastic surgery practice’s ability to reopen and resume procedures safely. This aligns with findings from an ASPS national consumer survey released in May, which revealed an overall positive attitude towards plastic surgery procedures even among those who are interested but have not undergone procedures before.
While ASPS anticipates a decrease in the total number of cosmetic procedures in 2020 due to the COVID-19 pandemic, the society forecasts a strong demand for treatments as practices reopen for in-office procedures. The number of cosmetic surgical procedures remained steady in 2019 vs. 2018 with 1.8 million surgical procedures performed.
The Top 10 cosmetic surgical procedures performed in 2019 were:
Breast...
Aesthetics Biomedical (ABM) has entered into a distribution and marketing partnership with Plasma Concepts for the PlasmaMD and Plasma+ plasma energy devices, formerly known as Genesis and Revelation. The partnership will help expand the branding and availability of the devices in the U.S., while growing ABM’s portfolio of aesthetic devices and treatments.
“At the core of Aesthetics Biomedical our mission has and will always be to innovate and elevate the patient experience without sacrificing results. Our partnership with Plasma Concepts adds these leading plasma energy devices into our portfolio, addressing innovation in a relatively untapped category, but uniquely complementing our existing products of SoME Skincare, and Vivace RF Microneedle,” said MaryAnn Guerra, president and CEO of Aesthetics Biomedical. “This collection of devices further enhances our skincare treatment offerings with another proprietary technology. We are thrilled to work with the Plasma Concepts team to take advantage of their amazing sales skills and together bring these amazing devices to providers.”
Both the compact, handheld PlasmaMD and Plasma+ devices, feature the proprietary ARC Energy Technology, which delivers the plasma...
Think of your most valuable employees—the ones who know the ins and outs of your practice, keep your office running smoothly, and are respected and liked by patients and staff. Now suppose those star staffers suddenly quit. How would that affect your day-to-day practice and profits?
Owners of thriving aesthetic practices know that knowledgeable, motivated, long-term employees are key to their success. And it’s not just high turnover rates that can damage a practice. Unhappy, dissatisfied team members can also wreak havoc on your bottom line. “If staff members are not happy, it can... more »
Patients who suffer from rosacea may exhibit any number of uncomfortable symptoms, from flushing and dilated capillaries to papules, pustules and ocular irritation. Treatment options similarly vary, as do theories as to what the underlying causes of rosacea may be. While recent research highlights cardiovascular links and explores the potential role of facial microorganisms, experts agree that the best treatments for rosacea target the chronic inflammation of the skin and body, and require a holistic approach to patient care. Patients most commonly present with erythematotelangiectatic... more »
At age six, Julius Few, MD, already knew exactly what he wanted to be when he grew up: a doctor—specifically, a surgeon. His inspiration: Dr. Quincy, a forensic pathologist played by actor Jack Klugman in the 1970s television series Quincy M.E. Of course, Dr. Quincy’s fictitious patients were dead, but that fact escaped the young Julius Few.
“Quincy was a sleuth,” says Dr. Few. “When I saw him operating on people, I thought that was the coolest thing and I knew that was what I wanted to do.”
Today, Dr. Few is the director and founder of The Few Institute for... more »
